2025-09-012026-08-312026-08-31falseSC572929THE EYE CLINIC (SCOTLAND) LTD2026-10-1486220falseiso4217:GBPxbrli:pureSC5729292025-08-31SC5729292026-08-31SC5729292025-09-012026-08-31SC5729292024-08-31SC5729292025-08-31SC5729292024-09-012025-08-31SC572929bus:SmallEntities2025-09-012026-08-31SC572929bus:AuditExempt-NoAccountantsReport2025-09-012026-08-31SC572929bus:FullAccounts2025-09-012026-08-31SC572929bus:PrivateLimitedCompanyLtd2025-09-012026-08-31SC572929core:WithinOneYear2026-08-31SC572929core:AfterOneYear2026-08-31SC572929core:WithinOneYear2025-08-31SC572929core:AfterOneYear2025-08-31SC572929core:ShareCapital2026-08-31SC572929core:SharePremium2026-08-31SC572929core:RevaluationReserve2026-08-31SC572929core:OtherReservesSubtotal2026-08-31SC572929core:RetainedEarningsAccumulatedLosses2026-08-31SC572929core:ShareCapital2025-08-31SC572929core:SharePremium2025-08-31SC572929core:RevaluationReserve2025-08-31SC572929core:OtherReservesSubtotal2025-08-31SC572929core:RetainedEarningsAccumulatedLosses2025-08-31SC572929core:LandBuildings2026-08-31SC572929core:PlantMachinery2026-08-31SC572929core:Vehicles2026-08-31SC572929core:FurnitureFittings2026-08-31SC572929core:OfficeEquipment2026-08-31SC572929core:NetGoodwill2026-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2026-08-31SC572929core:ListedExchangeTraded2026-08-31SC572929core:UnlistedNon-exchangeTraded2026-08-31SC572929core:LandBuildings2025-08-31SC572929core:PlantMachinery2025-08-31SC572929core:Vehicles2025-08-31SC572929core:FurnitureFittings2025-08-31SC572929core:OfficeEquipment2025-08-31SC572929core:NetGoodwill2025-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2025-08-31SC572929core:ListedExchangeTraded2025-08-31SC572929core:UnlistedNon-exchangeTraded2025-08-31SC572929core:LandBuildings2025-09-012026-08-31SC572929core:PlantMachinery2025-09-012026-08-31SC572929core:Vehicles2025-09-012026-08-31SC572929core:FurnitureFittings2025-09-012026-08-31SC572929core:OfficeEquipment2025-09-012026-08-31SC572929core:NetGoodwill2025-09-012026-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2025-09-012026-08-31SC572929core:ListedExchangeTraded2025-09-012026-08-31SC572929core:UnlistedNon-exchangeTraded2025-09-012026-08-31SC572929core:MoreThanFiveYears2025-09-012026-08-31SC572929core:Non-currentFinancialInstruments2026-08-31SC572929core:Non-currentFinancialInstruments2025-08-31SC572929dpl:CostSales2025-09-012026-08-31SC572929dpl:DistributionCosts2025-09-012026-08-31SC572929core:LandBuildings2025-09-012026-08-31SC572929core:PlantMachinery2025-09-012026-08-31SC572929core:Vehicles2025-09-012026-08-31SC572929core:FurnitureFittings2025-09-012026-08-31SC572929core:OfficeEquipment2025-09-012026-08-31SC572929dpl:AdministrativeExpenses2025-09-012026-08-31SC572929core:NetGoodwill2025-09-012026-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2025-09-012026-08-31SC572929dpl:GroupUndertakings2025-09-012026-08-31SC572929dpl:ParticipatingInterests2025-09-012026-08-31SC572929dpl:GroupUndertakingscore:ListedExchangeTraded2025-09-012026-08-31SC572929core:ListedExchangeTraded2025-09-012026-08-31SC572929dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-09-012026-08-31SC572929core:UnlistedNon-exchangeTraded2025-09-012026-08-31SC572929dpl:CostSales2024-09-012025-08-31SC572929dpl:DistributionCosts2024-09-012025-08-31SC572929core:LandBuildings2024-09-012025-08-31SC572929core:PlantMachinery2024-09-012025-08-31SC572929core:Vehicles2024-09-012025-08-31SC572929core:FurnitureFittings2024-09-012025-08-31SC572929core:OfficeEquipment2024-09-012025-08-31SC572929dpl:AdministrativeExpenses2024-09-012025-08-31SC572929core:NetGoodwill2024-09-012025-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-31SC572929dpl:GroupUndertakings2024-09-012025-08-31SC572929dpl:ParticipatingInterests2024-09-012025-08-31SC572929dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-31SC572929core:ListedExchangeTraded2024-09-012025-08-31SC572929dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-31SC572929core:UnlistedNon-exchangeTraded2024-09-012025-08-31SC572929core:NetGoodwill2026-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2026-08-31SC572929core:LandBuildings2026-08-31SC572929core:PlantMachinery2026-08-31SC572929core:Vehicles2026-08-31SC572929core:FurnitureFittings2026-08-31SC572929core:OfficeEquipment2026-08-31SC572929core:AfterOneYear2026-08-31SC572929core:WithinOneYear2026-08-31SC572929core:ListedExchangeTraded2026-08-31SC572929core:UnlistedNon-exchangeTraded2026-08-31SC572929core:ShareCapital2026-08-31SC572929core:SharePremium2026-08-31SC572929core:RevaluationReserve2026-08-31SC572929core:OtherReservesSubtotal2026-08-31SC572929core:RetainedEarningsAccumulatedLosses2026-08-31SC572929core:NetGoodwill2025-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2025-08-31SC572929core:LandBuildings2025-08-31SC572929core:PlantMachinery2025-08-31SC572929core:Vehicles2025-08-31SC572929core:FurnitureFittings2025-08-31SC572929core:OfficeEquipment2025-08-31SC572929core:AfterOneYear2025-08-31SC572929core:WithinOneYear2025-08-31SC572929core:ListedExchangeTraded2025-08-31SC572929core:UnlistedNon-exchangeTraded2025-08-31SC572929core:ShareCapital2025-08-31SC572929core:SharePremium2025-08-31SC572929core:RevaluationReserve2025-08-31SC572929core:OtherReservesSubtotal2025-08-31SC572929core:RetainedEarningsAccumulatedLosses2025-08-31SC572929core:NetGoodwill2024-08-31SC572929core:IntangibleAssetsOtherThanGoodwill2024-08-31SC572929core:LandBuildings2024-08-31SC572929core:PlantMachinery2024-08-31SC572929core:Vehicles2024-08-31SC572929core:FurnitureFittings2024-08-31SC572929core:OfficeEquipment2024-08-31SC572929core:AfterOneYear2024-08-31SC572929core:WithinOneYear2024-08-31SC572929core:ListedExchangeTraded2024-08-31SC572929core:UnlistedNon-exchangeTraded2024-08-31SC572929core:ShareCapital2024-08-31SC572929core:SharePremium2024-08-31SC572929core:RevaluationReserve2024-08-31SC572929core:OtherReservesSubtotal2024-08-31SC572929core:RetainedEarningsAccumulatedLosses2024-08-31SC572929core:AfterOneYear2025-09-012026-08-31SC572929core:WithinOneYear2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:CostValuation2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-012026-08-31SC572929core:Non-currentFinancialInstrumentscore:CostValuation2026-08-31SC572929core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-08-31SC572929core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-08-31SC572929core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-08-31SC572929core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-08-31SC572929core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-08-31SC572929core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-08-31SC572929core:Non-currentFinancialInstrumentscore:CostValuation2025-08-31SC572929core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-31SC572929core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-31SC572929bus:Director12025-09-012026-08-31

THE EYE CLINIC (SCOTLAND) LTD

Registered Number
SC572929
(Scotland)

Unaudited Financial Statements for the Year ended
31 August 2026

THE EYE CLINIC (SCOTLAND) LTD
Company Information
for the year from 1 September 2025 to 31 August 2026

Director

SABOOR, Tariq, Dr

Company Secretary

CHEEMA, Abdur-Rahman Tariq

Registered Address

Darnallan House Blairforkie Drive
Bridge Of Allan
Stirling
FK9 4PE

Registered Number

SC572929 (Scotland)
THE EYE CLINIC (SCOTLAND) LTD
Balance Sheet as at
31 August 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets3-43,578
-43,578
Current assets
Debtors4872,677820,844
Cash at bank and on hand1,433,3071,290,014
2,305,9842,110,858
Creditors amounts falling due within one year5(119,796)(168,544)
Net current assets (liabilities)2,186,1881,942,314
Total assets less current liabilities2,186,1881,985,892
Net assets2,186,1881,985,892
Capital and reserves
Called up share capital100100
Profit and loss account2,186,0881,985,792
Shareholders' funds2,186,1881,985,892
The financial statements were approved and authorised for issue by the Director on 14 October 2026, and are signed on its behalf by:
SABOOR, Tariq, Dr
Director
Registered Company No. SC572929
THE EYE CLINIC (SCOTLAND) LTD
Notes to the Financial Statements
for the year ended 31 August 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are initially recorded at cost and subsequently at cost less depreciation. The depreciation is calculated at the below rates.

Reducing balance (%)
Plant and machinery25
Vehicles25
Office Equipment25
Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financialinstruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortized cost using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20262025
Average number of employees during the year55
3.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 September 252,59458,69595362,242
Disposals(2,594)(58,695)(953)(62,242)
Depreciation and impairment
At 01 September 2510818,34321318,664
Charge for year5204,203774,800
On disposals(628)(22,546)(290)(23,464)
Net book value
At 31 August 26----
At 31 August 252,48640,35274043,578
4.Debtors: amounts due within one year

2026

2025

££
Other debtors872,677820,844
Total872,677820,844
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables-6,532
Taxation and social security69,155117,283
Other creditors43,50743,319
Accrued liabilities and deferred income7,1341,410
Total119,796168,544
6.Related party transactions
Included in creditors due within 12 months is an amount of £43,507 (2025: £42,606) due to the director. Included in other debtor is an amount of £79,301 (2025: £67,001) due from Premier Eye Clinic and Laser Centre Ltd, £750,940 (2025: £750,940) due from TR Medic Ltd and £41,170 (2025: £1,284) due from Premier Medicare Ltd, companies connected to the director.